Isabel Graupera

Sequential changes in urinary biomarker levels in patients with cirrhosis and severe hepatorenal syndrome.

Solé C, Ma AT, Solà E, Carol M, Fabrellas N, Juanola A, Napoleone L, Gratacós-Ginès J, Bassegoda O, Cervera M, Pérez M, Rubio AB, Avitabile E, Morales-Ruiz M, Graupera I, Pose E, Kamath PS, Ginès P.

Liver Int. 2021 Nov. 41(11):2729-2732. PMID: 34569697

A Distinctive NAFLD Signature in Adipose Tissue from Women with Severe Obesity.

Osorio-Conles Ó, Vega-Beyhart A, Ibarzabal A, Balibrea JM, Graupera I, Rimola J, Vidal J, de Hollanda A.

Int J Mol Sci. 2021 Sep 29. 22(19). PMID: 34638880

Population screening for liver fibrosis: towards early diagnosis and intervention for chronic liver diseases.

Ginès P, Castera L, Lammert F, Graupera I, Serra-Burriel M, Allen AM, Wong VW, Hartmann P, Thiele M, Caballeria L, de Knegt RJ, Grgurevic I, Augustin S, Tsochatzis EA, Schattenberg JM, Guha IN, Martini A, Morillas RM, Garcia-Retortillo M, de Koning HJ, Fabrellas N, Pich J, Ma AT, Diaz MA, Roulot D, Newsome PN, Manns M, Kamath PS, Krag A.

Hepatology. 2021 Sep 19. PMID: 34537988

Urinary L-FABP is a promising prognostic biomarker of ACLF and mortality in patients with decompensated cirrhosis.

Juanola A, Graupera I, Elia C, Piano S, Solé C, Carol M, Pérez-Guasch M, Bassegoda O, Escudé L, Rubio AB, Cervera M, Napoleone L, Avitabile E, Ma AT, Fabrellas N, Pose E, Morales-Ruiz M, Jiménez W, Torres F, Crespo G, Solà E, Ginès P.

J Hepatol. 2021 Sep 13. PMID: 34530063

Ductular Reaction Promotes Intrahepatic Angiogenesis Via Slit2-Robo1 Signaling.

Coll M, Ariño S, Mártinez-Sánchez C, Garcia-Pras E, Gallego J, Moles A, Aguilar-Bravo B, Blaya D, Vallverdú J, Rubio-Tomás T, Lozano JJ, Pose E, Graupera I, Pol A, Bataller R, Geng JG, Ginès P, Fernandez M, Sancho-Bru P.

Hepatology. 2021 Sep 07. PMID: 34490644

Quantification of polyreactive immunoglobulin G facilitates the diagnosis of autoimmune hepatitis.

Taubert R, Engel B, Diestelhorst J, Hupa-Breier KL, Behrendt P, Baerlecken NT, Sühs KW, Janik MK, Zachou K, Sebode M, Schramm C, Londoño MC, Habes S, Oo YH, Lalanne C, Pape S, Schubert M, Hust M, Dübel S, Thevis M, Jonigk D, Beimdiek J, Buettner FFR, Drenth JP, Muratori L, Adams DH, Dyson JK, Renand A, Graupera I, Lohse AW, Dalekos GN, Milkiewicz P, Stangel M, Maasoumy B, Witte T, Wedemeyer H, Manns MP, Jaeckel E.

Hepatology. 2021 Sep 02. PMID: 34473365

Programmed Death Ligand 1 Is Overexpressed in Liver Macrophages in Chronic Liver Diseases, and Its Blockade Improves the Antibacterial Activity Against Infections.

Pose E, Coll M, Martínez-Sánchez C, Zeng Z, Surewaard BGJ, Català C, Velasco-de Andrés M, Lozano JJ, Ariño S, Fuster D, Niñerola-Bazán A, Graupera I, Muñoz É, Lozano F, Sancho-Bru P, Kubes P, Ginès P.

Hepatology. 2021 Jul. 74(1):296-311. PMID: 33219516

Interaction between metabolic syndrome and alcohol consumption, risk factors of liver fibrosis: A population-based study.

Pose E, Pera G, Torán P, Gratacós-Ginès J, Avitabile E, Expósito C, Díaz A, Graupera I, Rubio AB, Ginès P, Fabrellas N, Caballeria L.

Liver Int. 2021 07. 41(7):1556-1564. PMID: 33595176

Profiling circulating microRNAs in patients with cirrhosis and acute-on-chronic liver failure.

Blaya D, Pose E, Coll M, Lozano JJ, Graupera I, Schierwagen R, Jansen C, Castro P, Fernandez S, Sidorova J, Vasa-Nicotera M, Solà E, Caballería J, Trebicka J, Ginès P, Sancho-Bru P.

JHEP Rep. 2021 Apr. 3(2):100233. PMID: 33665588

Global burden of disease: acute-on-chronic liver failure, a systematic review and meta-analysis.

Mezzano G, Juanola A, Cardenas A, Mezey E, Hamilton JP, Pose E, Graupera I, Ginès P, Solà E, Hernaez R.

Gut. 2021 Jan 12. PMID: 33436495